We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 27

U.S. Supreme Court hears oral argument in Phoebe Putney hospital merger challenge

  • McDermott Will & Emery
  • -
  • USA
  • -
  • November 27 2012

In oral argument in FTC v Phoebe Putney Health System, Supreme Court Justices focused on whether the state legislature clearly articulated a state policy to displace competition with regulation, in a case challenging the application of the state action doctrine to a hospital merger to monopoly

Second Circuit to hear expedited appeal in “product hopping” suit

  • McDermott Will & Emery
  • -
  • USA
  • -
  • January 9 2015

On January 6, 2015, the Second Circuit granted defendants’ motion for an expedited appeal but denied their motion for a stay in New York v

Supreme Court limits availability of state action immunity from federal antitrust liability

  • McDermott Will & Emery
  • -
  • USA
  • -
  • February 20 2013

The Supreme Court decision in FTC v. Phoebe Putney Health System, Inc., makes clear that state action immunity from federal antitrust laws is

Court grants summary judgment in Omnicare v. UnitedHealth Group

  • McDermott Will & Emery
  • -
  • USA
  • -
  • February 3 2009

The decision in this gun-jumping case emphasizes the importance of antitrust guidance during pre-closing due diligence and agreement negotiation

Pharmacist order challenges Commission’s power of investigation

  • McDermott Will & Emery
  • -
  • European Union, France
  • -
  • February 6 2009

The French National Pharmacist Order has launched a challenge before the European Court of First Instance against the European Commission's powers of investigation in competition cases

Court grants summary judgment in Omnicare v. UnitedHealth Group

  • McDermott Will & Emery
  • -
  • USA
  • -
  • February 3 2009

The decision in this gun-jumping case emphasizes the importance of antitrust guidance during pre-closing due diligence and agreement negotiation

GlaxoSmithKline infringed competition rules by restricting parallel trade

  • McDermott Will & Emery
  • -
  • European Union, Greece
  • -
  • April 4 2008

Advocate General Ruiz-Jarabo has delivered a non-binding opinion to the European Court of Justice (ECJ), finding that GlaxoSmithKline Plc (GSK) abused its dominant position by limiting distribution of certain pharmaceuticals to Greek wholesalers

The extent of supply limitation on EU pharmaceutical trade

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • December 16 2008

In its 16 September 2008 judgment, the European Court of Justice (ECJ) gave further guidance on how a dominant pharmaceutical supplier can justify limiting supplies to wholesalers

Reverse payment settlements

  • McDermott Will & Emery
  • -
  • USA
  • -
  • November 7 2011

On Monday, a California state court of appeal affirmed a lower court's ruling upholding a "reverse payment" (pay-for-delay) settlement between Bayer (Bayer) AG and Barr Pharmaceuticals (Barr

Ninth Circuit affirms divestiture of consummated physician practice acquisition

  • McDermott Will & Emery
  • -
  • USA
  • -
  • February 27 2015

The U.S. Court of Appeals for the Ninth Circuit affirmed an Idaho federal district court’s decision ordering the divestiture of a physician practice